title: Neural and immune mechanisms in the pathogenesis of Parkinson's disease.
abstract: Although almost 50 years have passed since impaired dopaminergic transmission was identified as the main neurochemical defect in Parkinson's disease (PD), the cause of the disease remains unknown. A restricted number of biological mechanisms are likely to contribute to the process of cell death in the nigrostriatal pathway. These mechanisms include mitochondrial defects and enhanced formation of reactive oxygen species--leading to oxidative damage--and abnormal protein aggregation. In addition to or, possibly, intermingled with these mechanisms of neuronal damage there is another crucial factor: neuroinflammation. The inflammatory response associated with cell loss in the dopaminergic nigrostriatal tract and, more in general, the role of immune mechanisms are increasingly recognized in PD pathogenesis. Neuroinflammatory changes have been repeatedly demonstrated, in both neurotoxic and transgenic animal models of PD, as well as in PD patients. Transgenic models based on α-synuclein overexpression, in particular, have provided crucial insights into the correlation between this protein and the dichotomous response that microglia can activate, with the polarization toward a cytotoxic (M1) or cytoprotective (M2) phenotype. Full understanding of such mechanisms may set the ground for a fine tuning of the neuroinflammatory process that accompanies and sustains neurodegeneration, thereby opening new therapeutic perspectives for PD.
authors: Center for Research in Neurodegenerative Diseases, IRCCS National Neurological Institute C. Mondino, Via Mondino, 2, 27100 Pavia, Italy. fabio.blandini@mondino.it
authors: Fabio
authors: F
authors: Blandini
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology / Q000502:physiology; D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology / Q000502:physiology; D028361:Mitochondrial Diseases / Q000473:pathology / Q000503:physiopathology; D009420:Nervous System / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D009443:Neuritis / Q000473:pathology; D015213:Neuroimmunomodulation / Q000502:physiology; D018384:Oxidative Stress / Q000502:physiology; D010300:Parkinson Disease / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D051844:alpha-Synuclein / Q000378:metabolism / Q000502:physiology
chemical_list: D051844:alpha-Synuclein
references: J Neurosci. 2002 Mar 1;22(5):1763-71
references: 11880505
references: Neurobiol Dis. 2006 Dec;24(3):492-505
references: 17023164
references: PLoS One. 2010 Jan 20;5(1):e8784
references: 20098715
references: Parkinsonism Relat Disord. 2008;14 Suppl 2:S124-9
references: 18595767
references: Trends Mol Med. 2011 Dec;17(12):687-8
references: 21996344
references: Science. 1997 Jun 27;276(5321):2045-7
references: 9197268
references: Parkinsonism Relat Disord. 2010 Jan;16(1):57-9
references: 19487152
references: J Neurochem. 2009 Aug;110(3):966-75
references: 19549006
references: Neurosci Lett. 2008 Aug 22;441(2):158-62
references: 18582534
references: Brain Res. 1989 Jun 12;489(2):247-53
references: 2501002
references: Exp Neurol. 1996 Dec;142(2):313-22
references: 8934562
references: Trends Neurosci. 2005 Nov;28(11):571-3
references: 16165228
references: J Neuroimmunol. 2007 Feb;183(1-2):60-8
references: 17196666
references: J Neural Transm Suppl. 2002;(62):347-76
references: 12456078
references: Science. 2003 Oct 31;302(5646):841
references: 14593171
references: Lancet Neurol. 2009 Apr;8(4):382-97
references: 19296921
references: Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):334-9
references: 21268244
references: Mov Disord. 2010;25 Suppl 1:S123-30
references: 20187234
references: Nat Genet. 2010 Sep;42(9):781-5
references: 20711177
references: Nat Neurosci. 2007 Nov;10(11):1387-94
references: 17965659
references: Ann Neurol. 2005 Feb;57(2):168-75
references: 15668962
references: Neurosci Lett. 1994 Jan 3;165(1-2):208-10
references: 8015728
references: J Neuropathol Exp Neurol. 2008 Dec;67(12):1149-58
references: 19018246
references: J Biol Chem. 2002 Jan 18;277(3):1641-4
references: 11707429
references: Arch Neurol. 2003 Aug;60(8):1059-64
references: 12925360
references: Cell. 2010 Mar 19;140(6):918-34
references: 20303880
references: Ann Neurol. 1996 Oct;40(4):663-71
references: 8871587
references: J Neurochem. 2002 Jul;82(2):345-52
references: 12124435
references: Nat Genet. 1998 Feb;18(2):106-8
references: 9462735
references: Neurosci Lett. 2003 May 1;341(2):87-90
references: 12686372
references: Eur J Hum Genet. 2011 Jun;19(6):655-61
references: 21248740
references: Nat Neurosci. 2005 May;8(5):657-63
references: 15834418
references: Ann Neurol. 1989 Dec;26(6):719-23
references: 2557792
references: Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
references: 9600990
references: J Neurochem. 2008 Mar;104(6):1504-25
references: 18036154
references: CNS Drugs. 2007;21(10):789-97
references: 17850169
references: Cold Spring Harb Perspect Med. 2012 May;2(5):a009423
references: 22553500
references: Nature. 1997 Aug 28;388(6645):839-40
references: 9278044
references: Nat Genet. 2009 Dec;41(12):1308-12
references: 19915575
references: Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381
references: 22315722
references: Neurosci Lett. 1985 Dec 18;62(3):389-94
references: 3912685
references: Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7
references: 3872460
references: Mov Disord. 2007 Oct 15;22(13):1852-6
references: 17592621
references: Neurobiol Dis. 2011 Sep;43(3):663-8
references: 21684338
references: Mov Disord. 2008 Jan;23(1):101-6
references: 17994582
references: Ann Neurol. 1999 Oct;46(4):598-605
references: 10514096
references: Hum Mol Genet. 2011 Aug 15;20(16):3227-40
references: 21613270
references: Nat Rev Immunol. 2003 Jan;3(1):23-35
references: 12511873
references: Brain. 2011 May;134(Pt 5):1293-314
references: 21596768
references: Science. 2010 Feb 5;327(5966):656-61
references: 20133564
references: Eur J Neurosci. 2005 Sep;22(5):1158-68
references: 16176358
references: BMC Med Genet. 2011 Aug 03;12:104
references: 21812969
references: Antioxid Redox Signal. 2009 Sep;11(9):2151-66
references: 19243239
references: J Leukoc Biol. 2007 Nov;82(5):1083-94
references: 17675560
references: Exp Neurol. 2006 Feb;197(2):275-83
references: 16336966
references: Science. 2000 Nov 3;290(5493):985-9
references: 11062131
references: Mol Chem Neuropathol. 1991 Jun;14(3):153-97
references: 1958262
references: Acta Neuropathol. 2006 Sep;112(3):237-51
references: 16845533
references: Eur J Neurosci. 2002 Mar;15(6):991-8
references: 11918659
references: J Clin Invest. 2009 Jan;119(1):182-92
references: 19104149
references: Exp Neurol. 2007 Feb;203(2):370-80
references: 17010972
references: Ann Neurol. 2004 Feb;55(2):164-73
references: 14755719
references: Nat Genet. 2009 Dec;41(12):1303-7
references: 19915576
references: J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5
references: 9010393
references: Int J Neurosci. 2001 Jul;109(1-2):91-126
references: 11699344
references: Glia. 2013 Jan;61(1):10-23
references: 22615180
references: J Neurochem. 1997 Sep;69(3):1326-9
references: 9282961
references: J Neuroimmune Pharmacol. 2013 Mar;8(1):145-62
references: 23114889
references: Arch Neurol. 2009 Jan;66(1):102-8
references: 19139307
references: Glia. 2012 May;60(5):717-27
references: 22290798
references: Neurobiol Aging. 2012 Dec;33(12):2841-54
references: 22445325
references: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15558-63
references: 18809917
references: Science. 2010 Sep 24;329(5999):1663-7
references: 20798282
references: J Clin Neurosci. 2008 May;15(5):576-7
references: 18343119
references: Parkinsonism Relat Disord. 2008;14(4):286-90
references: 18042421
references: J Neurochem. 1990 Mar;54(3):823-7
references: 2154550
references: J Exp Med. 2011 Aug 1;208(8):1695-705
references: 21788405
references: Ann Neurol. 2003 Nov;54(5):599-604
references: 14595649
references: Drugs Aging. 2009;26(9):769-79
references: 19728750
references: Int J Neurosci. 2004 Feb;114(2):197-216
references: 14702208
references: Eur J Neurol. 2011 Nov;18(11):1336-42
references: 21457177
references: Neurobiol Aging. 2008 Nov;29(11):1690-701
references: 17537546
references: J Neurochem. 2012 Jul;122(2):404-14
references: 22537068
references: J Clin Invest. 2009 Nov;119(11):3257-65
references: 19855133
references: Neuroepidemiology. 2007;28(4):193-6
references: 17851257
references: Neurology. 1988 Aug;38(8):1285-91
references: 3399080
references: Expert Rev Neurother. 2006 Dec;6(12):1811-22
references: 17181428
references: Neurotoxicol Teratol. 1995 Jan-Feb;17(1):7-12
references: 7535890
references: Neurosci Lett. 1994 Oct 24;180(2):147-50
references: 7700568
references: Front Neurosci. 2011 Jun 29;5:80
references: 21747756
references: Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S17-20
references: 22166424
references: FEBS Lett. 2001 Jul 6;500(3):105-8
references: 11445065
references: J Immunol. 2009 Apr 1;182(7):4137-49
references: 19299711
references: Exp Neurol. 2009 Aug;218(2):247-56
references: 19332061
references: J Neuroimmune Pharmacol. 2013 Mar;8(1):94-117
references: 23054368
references: Glia. 2002 Nov;40(2):206-17
references: 12379908
references: Science. 1983 Feb 25;219(4587):979-80
references: 6823561
references: Glia. 2004 May;46(4):402-9
references: 15095370
references: Neurosci Lett. 1995 Jun 30;193(2):129-32
references: 7478158
references: Neuroscience. 2000;95(2):425-32
references: 10658622
references: Neurology. 1996 Dec;47(6 Suppl 3):S161-70
references: 8959985
references: Neurodegeneration. 1996 Jun;5(2):137-43
references: 8819134
references: Acta Neurol Scand. 2009 May;119(5):332-7
references: 18976327
references: Expert Rev Mol Med. 2011 Mar 21;13:e8
references: 21418705
references: Mov Disord. 2010 Nov 15;25(15):2493-500
references: 20922807
references: J Neurochem. 1999 Sep;73(3):1127-37
references: 10461904
references: Mov Disord. 2011 Jan;26(1):51-8
references: 21322019
references: Exp Neurol. 2005 Jun;193(2):279-90
references: 15869932
references: Mov Disord. 2010 Oct 30;25(14):2355-60
references: 20721917
references: Brain Res. 2003 Feb 28;964(2):288-94
references: 12576189
references: J Neurosci Res. 2003 Oct 15;74(2):278-85
references: 14515357
references: Ann Neurol. 1992;32 Suppl:S82-7
references: 1510385
references: Exp Neurol. 1999 Mar;156(1):50-61
references: 10192776
references: Neurology. 2007 Nov 6;69(19):1836-42
references: 17984451
references: Neurosci Lett. 1994 May 19;172(1-2):151-4
references: 8084523
references: Clin Interv Aging. 2010 Sep 07;5:229-38
references: 20852670
references: Neuroscience. 2012 Apr 19;208:85-96
references: 22342967
references: FASEB J. 2005 Apr;19(6):533-42
references: 15791003
references: Trends Neurosci. 2010 Dec;33(12):559-68
references: 20961626
references: Neurobiol Aging. 2008 May;29(5):739-52
references: 17166628
references: Front Pharmacol. 2012 Mar 08;3:33
references: 22408621
references: Cell Mol Life Sci. 2010 Oct;67(20):3435-47
references: 20577776
references: Int J Environ Res Public Health. 2011 Jul;8(7):2980-3018
references: 21845170
references: Mov Disord. 2010;25 Suppl 1:S49-54
references: 20187257
references: Mov Disord. 2006 Jul;21(7):964-9
references: 16550541
references: Science. 2004 May 21;304(5674):1120-2
references: 15155938
references: BMJ. 2011 Jan 20;342:d198
references: 21252104
references: Prog Neurobiol. 2000 Sep;62(1):63-88
references: 10821982
references: J Neuroinflammation. 2005 Jun 03;2:14
references: 15935098
references: Cochrane Database Syst Rev. 2011 Nov 09;(11):CD008454
references: 22071848
references: Neurobiol Dis. 2006 Feb;21(2):404-12
references: 16182554